688068 熱景生物
按盤價 
110.950 +11.970 (+12.093%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.792 | -5.929 | 0.863 | 30.580 | 121.897 |
| 總資產報酬率 ROA (%) | -0.728 | -5.538 | 0.774 | 25.046 | 96.133 |
| 投入資產回報率 ROIC (%) | -0.781 | -5.874 | 0.844 | 28.652 | 111.849 | 邊際利潤分析 |
| 銷售毛利率 (%) | 47.268 | 55.360 | 57.127 | 53.711 | 59.538 |
| 營業利潤率 (%) | -25.768 | -36.326 | 3.412 | 30.672 | 48.134 |
| 息稅前利潤/營業總收入 (%) | -33.773 | -42.941 | -5.074 | 29.290 | 48.151 |
| 淨利潤/營業總收入 (%) | -26.347 | -38.352 | 3.051 | 26.012 | 41.019 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 154.121 | 53.547 | -302.162 | 117.095 | 102.716 |
| 價值變動淨收益/利潤總額(%) | -44.155 | 4.984 | -157.972 | 1.015 | 0.964 |
| 營業外收支淨額/利潤總額(%) | 0.343 | 1.216 | -24.724 | -1.454 | -0.101 | 償債能力分析 |
| 流動比率 (X) | 5.375 | 5.479 | 4.467 | 3.517 | 3.429 |
| 速動比率 (X) | 5.081 | 5.125 | 3.737 | 3.215 | 3.077 |
| 資產負債率 (%) | 8.853 | 7.570 | 5.756 | 13.992 | 21.154 |
| 帶息債務/全部投入資本 (%) | 1.887 | 0.035 | 0.756 | 2.153 | 8.587 |
| 股東權益/帶息債務 (%) | 5,172.311 | 287,930.296 | 13,052.249 | 4,497.771 | 1,050.889 |
| 股東權益/負債合計 (%) | 1,030.192 | 1,221.581 | 1,638.419 | 611.307 | 368.803 |
| 利息保障倍數 (X) | 4.266 | 6.962 | 0.650 | -31.106 | 738.811 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 99.274 | 42.157 | 40.604 | 6.727 | 2.139 |
| 存貨周轉天數 (天) | 149.927 | 174.159 | 223.367 | 45.142 | 31.893 |
| 備註： | 即時報價更新時間為 16/05/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
